Publication of new data demonstrates significantly superior efficacy of XF-73 compared to a leading topical antibiotic against MRSA in skin infection models
PharmiWeb,
Brighton, United Kingdom – 31 July 2023 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company focused on the…